Gilead Sciences
Biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases. Learn more
Launch date
Employees
Market cap
AUD159.3b
Enterprise valuation
AUD185.8b (Public information from Sep 2024)
Share price
€68.88 GILD.MI
Foster City California (HQ)
No columns specified